Amy Tiersten, MD
Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology · Icahn School of Medicine at Mount Sinai · NYU Langone Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amy Tiersten, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:03 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06040970 · Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerIcahn School of Medicine at Mount Sinai · recruiting · Ovarian Cancer, Malignant Neoplasm of Uterus · principal investigator
- Ph1/Ph2NCT05095207 · Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast CancerIcahn School of Medicine at Mount Sinai · recruiting · Breast Cancer, Metastasis · principal investigator
- Ph2NCT04561817 · To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian CancerIcahn School of Medicine at Mount Sinai · withdrawn · Ovarian Neoplasms · principal investigator
- Ph1NCT03430518 · Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian CancerAmy Tiersten · completed · HER2-Negative Metastatic Breast Cancer, Recurrent Ovarian Cancer · principal investigator
- Ph1/Ph2NCT03304080 · Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastIcahn School of Medicine at Mount Sinai · active not recruiting · Breast Neoplasms, Breast Diseases · principal investigator
- Ph1NCT02936206 · Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.Icahn School of Medicine at Mount Sinai · terminated · Breast Cancer · principal investigator
- Ph2NCT02531932 · Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast CancerAmy Tiersten · completed · Breast Cancer · principal investigator
- N/ANCT02081612 · Comparison of Nutrition Education Alone or With Acupuncture for Weight Loss in Breast Cancer Patients Post-ChemotherapyIcahn School of Medicine at Mount Sinai · completed · Breast Cancer · study director
- Ph2NCT01127763 · RAD001 Plus Carboplatin in Breast Cancer PatientsNYU Langone Health · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.